Literature DB >> 25354189

Linear aliphatic dialkynes as alternative linkers for double-click stapling of p53-derived peptides.

Yu Heng Lau1, Peterson de Andrade, Grahame J McKenzie, Ashok R Venkitaraman, David R Spring.   

Abstract

We investigated linear aliphatic dialkynes as a new structural class of i,i+7 linkers for the double-click stapling of p53-based peptides. The optimal combination of azido amino acids and dialkynyl linker length for MDM2 binding was determined. In a direct comparison between aliphatic and aromatic staple scaffolds, the aliphatic staples resulted in superior binding to MDM2 in vitro and superior p53-activating capability in cells when using a diazidopeptide derived from phage display. This work demonstrates that the nature of the staple scaffold is an important factor that can affect peptide bioactivity in cells.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  anticancer agents; click chemistry; macrocycles; peptides; stapling

Mesh:

Substances:

Year:  2014        PMID: 25354189     DOI: 10.1002/cbic.201402374

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  12 in total

1.  Dual-purpose linker for alpha helix stabilization and imaging agent conjugation to glucagon-like peptide-1 receptor ligands.

Authors:  Liang Zhang; Tejas Navaratna; Jianshan Liao; Greg M Thurber
Journal:  Bioconjug Chem       Date:  2015-01-28       Impact factor: 4.774

2.  Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation.

Authors:  Ewa D Micewicz; Shantanu Sharma; Alan J Waring; Hai T Luong; William H McBride; Piotr Ruchala
Journal:  Int J Pept Res Ther       Date:  2015-08-19       Impact factor: 1.931

3.  A two-component 'double-click' approach to peptide stapling.

Authors:  Yu Heng Lau; Yuteng Wu; Peterson de Andrade; Warren R J D Galloway; David R Spring
Journal:  Nat Protoc       Date:  2015-03-12       Impact factor: 13.491

Review 4.  Designing helical peptide inhibitors of protein-protein interactions.

Authors:  Raheleh Rezaei Araghi; Amy E Keating
Journal:  Curr Opin Struct Biol       Date:  2016-04-25       Impact factor: 6.809

5.  Perfluoroarene-Based Peptide Macrocycles to Enhance Penetration Across the Blood-Brain Barrier.

Authors:  Colin M Fadzen; Justin M Wolfe; Choi-Fong Cho; E Antonio Chiocca; Sean E Lawler; Bradley L Pentelute
Journal:  J Am Chem Soc       Date:  2017-10-30       Impact factor: 15.419

Review 6.  Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes.

Authors:  Marta Pelay-Gimeno; Adrian Glas; Oliver Koch; Tom N Grossmann
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-26       Impact factor: 15.336

7.  Development of a Multifunctional Benzophenone Linker for Peptide Stapling and Photoaffinity Labelling.

Authors:  Yuteng Wu; Lasse B Olsen; Yu Heng Lau; Claus Hatt Jensen; Maxim Rossmann; Ysobel R Baker; Hannah F Sore; Súil Collins; David R Spring
Journal:  Chembiochem       Date:  2016-03-16       Impact factor: 3.164

8.  Constraining an Irregular Peptide Secondary Structure through Ring-Closing Alkyne Metathesis.

Authors:  Philipp M Cromm; Kerstin Wallraven; Adrian Glas; David Bier; Alois Fürstner; Christian Ottmann; Tom N Grossmann
Journal:  Chembiochem       Date:  2016-09-06       Impact factor: 3.164

9.  Orthogonal ring-closing alkyne and olefin metathesis for the synthesis of small GTPase-targeting bicyclic peptides.

Authors:  Philipp M Cromm; Sebastian Schaubach; Jochen Spiegel; Alois Fürstner; Tom N Grossmann; Herbert Waldmann
Journal:  Nat Commun       Date:  2016-04-14       Impact factor: 14.919

10.  Development of Cell-Permeable, Non-Helical Constrained Peptides to Target a Key Protein-Protein Interaction in Ovarian Cancer.

Authors:  Mareike M Wiedmann; Yaw Sing Tan; Yuteng Wu; Shintaro Aibara; Wenshu Xu; Hannah F Sore; Chandra S Verma; Laura Itzhaki; Murray Stewart; James D Brenton; David R Spring
Journal:  Angew Chem Int Ed Engl       Date:  2016-12-05       Impact factor: 16.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.